Witness Testimony

Dr. Jonathan Couey, a biomedical scientist with expertise in virology and molecular genetics, testified regarding concerns about the design and implementation of mRNA COVID-19 vaccines. He described the technology as a novel gene-based platform utilizing lipid nanoparticles to deliver genetic instructions encoding the spike protein. He raised questions about biodistribution, persistence of spike protein expression, and potential unintended biological effects, asserting that the technology was deployed under emergency authorization without long-term safety data.
He testified that regulatory agencies relied on limited trial data and that post-marketing surveillance systems may not have adequately captured adverse events. He expressed concern about immune imprinting, repeated booster administration, and the impact of widespread vaccination during active viral circulation. He further argued that the vaccines functioned as a form of genetic therapy and should have been regulated under stricter standards traditionally applied to gene-based interventions.
Dr. Couey emphasized the precautionary principle, particularly for low-risk populations such as children and young adults. He stated that informed consent requires full disclosure of uncertainties and potential risks, and he criticized what he characterized as censorship of dissenting scientific views. He concluded by advocating for independent investigation, transparent regulatory review, and reconsideration of mass vaccination strategies.